Company / Income Tax per Share
Amylyx Pharmaceuticals, Inc. Income Tax per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2025
5-year range
-$0.01 / $0.11
FY2022-FY2025
Trend
+107.3%
vs FY2024
Sector context
#106 of 201
Health Care
What the data says
At $0.00, Amylyx Pharmaceuticals, Inc.'s income tax per share ranks #96 of 201 in the Health Care sector. Income Tax per Share returned to growth in FY2025 after 2 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -84.4%.
Improved from $0.07 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -84.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 201 in Health CareTop 47% of 201This company $0.00 Sector average $1.35
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 107.3% year-over-year.
- Ranks #106 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +107.3% |
| FY2024 | -$0.01 | -107.7% |
| FY2023 | $0.07 | -32.7% |
| FY2022 | $0.11 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026